000			01792 a2200481 4500
005			20250515171813.0
264		0	_c20091110
008			200911s 0 0 eng d
022			_a1879-0712
024	7		_a10.1016/j.ejphar.2009.04.058 _2doi
040			_aNLM _beng _cNLM
100	1		_aKumar, Puneet
245	0	0	_aProtective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations. _h[electronic resource]
260			_bEuropean journal of pharmacology _cAug 2009
300			_a91-101 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAnimals
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aBrain _xdrug effects
650	0	4	_aBrain Chemistry _xdrug effects
650	0	4	_aCholinesterase Inhibitors _xpharmacology
650	0	4	_aCorpus Striatum _xdrug effects
650	0	4	_aHuntington Disease _xchemically induced
650	0	4	_aLipid Peroxidation
650	0	4	_aMale
650	0	4	_aMaze Learning _xdrug effects
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aNeuroprotective Agents _xpharmacology
650	0	4	_aNitrites _xmetabolism
650	0	4	_aNitro Compounds
650	0	4	_aOxidative Stress _xdrug effects
650	0	4	_aPhenylcarbamates _xpharmacology
650	0	4	_aPropionates
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aRivastigmine
650	0	4	_aRotarod Performance Test
700	1		_aKumar, Anil
773	0		_tEuropean journal of pharmacology _gvol. 615 _gno. 1-3 _gp. 91-101
856	4	0	_uhttps://doi.org/10.1016/j.ejphar.2009.04.058 _zAvailable from publisher's website
999			_c18873111 _d18873111